Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Dec;9(12):4908-4911.
doi: 10.21037/jtd.2017.11.103.

Locally advanced non-small cell lung cancer treatment: another step forward

Pier Luigi Filosso  1 , Francesco Guerrera  1 , Paolo Olivo Lausi  1 , Enrico Ruffini  1
Affiliations
Editorial

Locally advanced non-small cell lung cancer treatment: another step forward

Pier Luigi Filosso et al. J Thorac Dis. 2017 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

References

    1. Legras A, Mordant P, Arame A, et al. Long-term survival of patients with pN2 lung cancer ac-cording to the pattern of lymphatic spread. Ann Thorac Surg 2014;97:1156-62. 10.1016/j.athoracsur.2013.12.047 - DOI - PubMed
    1. Guerrera F, Renaud S, Tabbó F, et al. Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas. Eur J Cardiothorac Surg 2017;51:680-8. 10.1093/ejcts/ezw362 - DOI - PubMed
    1. Bradley JD, Paulus R, Komaki R, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for pa-tients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol 2015;16:187-99. 10.1016/S1470-2045(14)71207-0 - DOI - PMC - PubMed
    1. Bradley JD, Moughan J, Graham MV, et al. A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117. Int J Radiat Oncol Biol Phys 2010;77:367-72. 10.1016/j.ijrobp.2009.04.029 - DOI - PMC - PubMed
    1. Senan S, Brade A, Wang LH, et al. PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer. J Clin Oncol 2016;34:953-62. 10.1200/JCO.2015.64.8824 - DOI - PubMed